Angeliq Tablet, Film Coated
Product Images NDC 50419-483

5 FDA label images from Bayer Healthcare Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Angeliq (NDC 50419-483). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bayer Healthcare Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Angeliq 01)

Chemical Structure (Angeliq 01)
Chemical structure diagram showing the molecules of Drospirenone and Estradiol, the active ingredients in Angeliq tablets. The diagram includes atomic connections and molecular structure of both compounds with labels.*
FDA Label Image

Figure 1 (Angeliq 02)

Figure 1 (Angeliq 02)
Two line graphs depict mean serum concentrations of drospirenone and estradiol over 24 hours. The left graph shows concentrations peaking early then declining gradually, with drospirenone concentrations lower than estradiol. The right graph shows similar trends with higher peak levels of both compounds, including error bars indicating variability at each time point.*
FDA Label Image

Figure 2 (Angeliq 03)

Figure 2 (Angeliq 03)
A line chart titled 'Proportion of subjects with any bleeding/spotting by month' displaying monthly percentages over 12 months. It compares two dosages of drospirenone and estradiol (DRSP/E2): 0.25 mg/0.5 mg and 0.5 mg/1.0 mg, showing the proportion of subjects with bleeding or spotting on the y-axis and months on the x-axis. The graph uses squares for the lower dose and circles for the higher dose to differentiate data series.*
FDA Label Image

Angeliq Serialized Carton .5 (Image 04)

Angeliq Serialized Carton .5 (Image 04)
Angeliq tablets packaging label showing drospirenone and estradiol 0.5 mg/1 mg strength. The label states the film-coated oral tablet dosage form and includes Bayer HealthCare Pharmaceuticals Inc. branding. The package indicates a 28-tablet supply with dosage information visible on multiple panels.*
FDA Label Image

.25 mg Serialized Label (Image 05)

.25 mg Serialized Label (Image 05)
Packaging label for Angeliq tablets containing drospirenone and estradiol at a strength of 0.25 mg/0.5 mg. The label includes dosage form information as film-coated tablets, oral route, and lists Bayer HealthCare Pharmaceuticals Inc. as the labeler. The box is designed for 28 tablets and features purple and yellow coloring with the Bayer logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.